Ascendis Pharma A/S (ASND) Reports Positive Week 52 Data from Phase 2 New InsiGHTS Trial
Last Update:
4 4 月, 2026
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.